Prevalence and Predictors of Influenza and Pneumococcal Vaccine Uptake in Patients with Diabetes

摘要

The reported prevalence of diabetes mellitus in Ireland is 4.7%, though the actual figure is higher due to the number of undiagnosed cases.1 People with diabetes have a higher susceptibility to morbidity, mortality and hospitalizations due to influenza and pneumococcal disease compared to the general population.2 Accordingly, diabetes is prioritised as a high risk condition in Ireland and many other countries, with vaccination recommended against these diseases under national guidelines. The Immunisation Guidelines for Ireland and the American Diabetes Association (ADA) recommend that people with diabetes receive the seasonal influenza and pneumococcal vaccines. The influenza vaccine is recommended annually, while the pneumococcal vaccine is recommended at least once over a patient's lifetime.